Abbott has reported late-breaking five-year positive data from a trial of its Amplatzer Amulet left atrial appendage (LAA) occluder for reducing the long-term need for blood-thinning medication in ...

The secret lies in the orchid’s mysterious finger-like appendage. “I knew there had to be more to it than just an odd-looking quirk,” says Kenji Suetsugu at Kobe University in Japan.

Abbott reported fourth-quarter results that missed the consensus sales forecast — but medical device sales remain a bright ...

Abbott (NYSE:ABT) today highlighted significant growth within its Diabetes business amid its fourth-quarter results for 2024.

Medscape Medical News, December 11, 2023 TCT 2023 Amulet and Watchman Equal for Left Atrial Appendage Closure The Amulet and Watchman FLX devices for left atrial appendage closure produced ...